Barnett & Company, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Barnett & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$493.32 - $643.92 $50,811 - $66,323	-103 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$336.18 - $494.43 $1,008 - $1,483	-3 Reduced 2.83%	103 $50,000
Q4 2019 Jan 22, 2020	BUY	$274.13 - $376.51 $28,235 - $38,780	103 Added 3433.33%	106 $40,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $820 - $955	3 New	3 $1,000

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.